NCT03212170View on ClinicalTrials.gov

FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

November 14, 2024

Study Completion Date

December 31, 2025

Conditions
Invasive Breast Cancer
Interventions
DRUG

[18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging

18F-Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging tracer

Trial Locations (1)

53705

University of Wisconsin, Madison, Madison

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Wisconsin, Madison

OTHER